J Korean Ophthalmol Soc > Volume 53(8); 2012 > Article
Journal of the Korean Ophthalmological Society 2012;53(8):1112-1117.
DOI: https://doi.org/10.3341/jkos.2012.53.8.1112    Published online August 15, 2012.
Effects of Intravitreal Bevacizumab Injection in 3 Types of Macular Edema Secondary to Branch Retinal Vein Occlusion.
Yoon Soo Jang, Dong Won Lee
Myung-Gok Eye Research Institute, Department of Ophthalmology, Kim's Eye Hospital, College of Medicine, Konyang University, Seoul, Korea. mediceye@kimeye.com
망막분지정맥폐쇄에서 황반부종 형태에 따른 유리체강내 베바시주맙 주입술 효과와 주입횟수 비교
장윤수⋅이동원
Myung-Gok Eye Research Institute, Department of Ophthalmology, Kim’s Eye Hospital, College of Medicine, Konyang University, Seoul, Korea
Abstract
PURPOSE
To compare the effects of intravitreal bevacizumab injection (IVB) in 3 types of macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: Patients with macular edema secondary to BRVO with at least 1-year follow-up after IVB were included in the present retrospective study. The authors classified the macular edema into 3 types according to OCT findings: diffuse macular edema (type 1), cystoid macular edema (type 2), and serous retinal detachment (type 3). The clinical outcome indicators were best corrected visual acuity, central macular thickness (CMT), and total number of injections. RESULTS: The total injection number was significantly higher in type 2 than type 3 (p = 0.02). Changes in CMT were significantly different between type 2 and type 3 (p = 0.03). CMT decreased significantly after IVB in all types of macular edema. CONCLUSIONS: Morphologic classification of macular edema with OCT is useful for predicting efficacy of IVB in macular edema secondary to BRVO.
Key Words: Avastin;BRVO;Intravitreal bevacizumab injection;Macular edema;OCT


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next